title: [Effect of tumor size and lymph node status on the prognosis of pancreatic cancer].
abstract: Between 1982 and 1987 186 patients with a carcinoma of the pancreas underwent surgery. In 69 patients (37%) a resective surgical procedure was performed. In these patients, lymph node staging was conducted intraoperatively. The operative mortality of the resection was 4.3%. The median survival of the resected patients with papillary carcinoma was 21 months and of the patients with ductal pancreatic carcinoma 7 months. A correlation between survival time and frequency as well as localization of the lymph node attack could be established. Only patients in the TNM stage I of a ductal carcinoma appeared to have profited significantly from the resection compared to the palliative procedure.
authors.affiliation: Abteilung für Allgemeine Chirurgie, der Universitätskliniken Ulm/D.
authors.forename: R
authors.initials: R
authors.lastname: Bittner
authors.forename: R
authors.initials: R
authors.lastname: Roscher
authors.forename: F
authors.initials: F
authors.lastname: Safi
authors.forename: H P
authors.initials: HP
authors.lastname: Dopfer
authors.forename: E
authors.initials: E
authors.lastname: Schölzel
authors.forename: H G
authors.initials: HG
authors.lastname: Beger
mesh_terms: D000182:ACTH Syndrome, Ectopic / Q000601:surgery; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014670:Ampulla of Vater / Q000601:surgery; D002276:Carcinoid Tumor / Q000601:surgery; D002277:Carcinoma / Q000601:surgery; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000601:surgery; D003138:Common Bile Duct Neoplasms / Q000601:surgery; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000601:surgery*; D011183:Postoperative Complications / Q000401:mortality*; D011379:Prognosis
vernacular_title: Der Einfluss von Tumorgrösse und Lymphknotenstatus auf die Prognose des Pankreascarcinoms.